EAM Investors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-85,525
Closed -$2.76M 237
2025
Q1
$2.76M Buy
+85,525
New +$3.17M 0.48% 102
2021
Q3
Sell
-32,987
Closed -$2.62M 289
2021
Q2
$2.62M Buy
+32,987
New +$2.4M 0.4% 69
2020
Q3
Sell
-66,915
Closed -$3.01M 277
2020
Q2
$3.01M Sell
66,915
-18,801
-22% -$819K 0.66% 26
2020
Q1
$2.88M Buy
+85,716
New +$3.08M 0.89% 13
2019
Q1
Sell
-95,379
Closed -$2.92M 257
2018
Q4
$2.92M Sell
95,379
-52,031
-35% -$1.62M 0.79% 18
2018
Q3
$5.16M Sell
147,410
-8,001
-5% -$253K 0.77% 8
2018
Q2
$4.2M Buy
+155,411
New +$3.65M 0.66% 23
2015
Q4
Sell
-123,281
Closed -$2.7M 308
2015
Q3
$2.7M Sell
123,281
-69,071
-36% -$1.73M 0.43% 79
2015
Q2
$4.74M Buy
192,352
+41,166
+27% +$919K 0.55% 36
2015
Q1
$3.1M Buy
+151,186
New +$2.93M 0.36% 146
2014
Q3
Sell
-126,554
Closed -$2.33M 316
2014
Q2
$2.33M Sell
126,554
-39,777
-24% -$662K 0.44% 47
2014
Q1
$3.13M Sell
166,331
-78,552
-32% -$1.61M 0.56% 26
2013
Q4
$4.57M Buy
244,883
+66,524
+37% +$967K 0.82% 9
2013
Q3
$1.96M Buy
+178,359
New +$1.76M 0.39% 72

Other funds holding ATRC

EAM Investors's ATRC Position: Q2 2025 in Review

EAM Investors sold out of AtriCure (ATRC) in Q2 2025, closing a stake of 85,525 shares — an estimated $2.76M sold.

EAM Investors first reported a position in ATRC in Q3 2013 and held it in 14 quarters. The position peaked at $5.16M in Q3 2018. 201 funds tracked by Wall St. Rank hold ATRC as of Q2 2025.

  • EAM Investors reported no remaining AtriCure position as of Q2 2025 after selling out during the quarter.
  • EAM Investors sold 85,525 AtriCure shares in Q2 2025, an estimated $2.76M.
  • EAM Investors first reported a position in AtriCure in Q3 2013 and held it in 14 quarters.
  • EAM Investors's AtriCure position peaked at $5.16M in Q3 2018.
  • 201 funds tracked by Wall St. Rank held AtriCure as of Q2 2025.

Based on EAM Investors's 13F filing for Q2 2025, filed 12 Aug 2025.